In line with reports of reduced CSF NPTX2 in AD and FTD associated with cognitive decline [35, 36, 37], the decrease of NPTXR in CJD suggests early synaptic degeneration driven by PrPSc‐induced toxicity. Here, NPTXR is linked to Alzheimer disease.